financetom
Business
financetom
/
Business
/
AstraZeneca to buy Fusion Pharma for $2 billion in cash
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AstraZeneca to buy Fusion Pharma for $2 billion in cash
Mar 19, 2024 12:24 AM

March 19 (Reuters) - AstraZeneca ( AZN ) said on Tuesday

it has agreed to buy clinical-stage biopharmaceutical company

Fusion Pharmaceuticals Inc ( FUSN ) for about $2 billion in

cash.

The drugmaker will pay $21 per Fusion share plus a

non-transferable contingent value right of $3 per share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alphabet Shares Are On The Rise Today: What's Going On?
Alphabet Shares Are On The Rise Today: What's Going On?
Jan 31, 2025
Alphabet Inc. ( GOOG )‘s stock is moving higher Friday ahead of its fourth-quarter earnings report, with analysts from Bank of America maintaining a positive outlook on the company's performance. What To Know: The firm noted that strong e-commerce ad spending and Meta's recent ad revenue beat point to potential upside for Google's ( GOOG ) advertising business in the...
Verizon Communications Insider Sold Shares Worth $453,155, According to a Recent SEC Filing
Verizon Communications Insider Sold Shares Worth $453,155, According to a Recent SEC Filing
Jan 31, 2025
11:21 AM EST, 01/31/2025 (MT Newswires) -- Kyle Malady, EVP and Group CEO-VZ Business, on January 29, 2025, sold 11,085 shares in Verizon Communications ( VZ ) for $453,155. Following the Form 4 filing with the SEC, Malady has control over a total of 32,697 common shares of the company, with 14,590 shares held directly and 18,107 controlled indirectly. SEC...
What's Going On With Bitfarms Stock Today?
What's Going On With Bitfarms Stock Today?
Jan 31, 2025
Bitfarms Ltd. ( BITF ) shares are trading slightly higher on Friday. The company has announced strategic steps to enhance its growth prospects. The cryptocurrency mining company has engaged two expert consultants, Appleby Strategy Group and World Wide Technology, to conduct a comprehensive feasibility analysis of its North American sites, particularly for high-performance computing and artificial intelligence. This collaboration aims...
Colgate-Palmolive Fourth-Quarter Sales Unexpectedly Fall; Issues 2025 Outlook
Colgate-Palmolive Fourth-Quarter Sales Unexpectedly Fall; Issues 2025 Outlook
Jan 31, 2025
11:18 AM EST, 01/31/2025 (MT Newswires) -- Colgate-Palmolive's ( CL ) fourth-quarter earnings came in ahead of Wall Street's estimates, while revenue posted a surprise decline amid weakness in North America and Latin America. Per-share adjusted earnings came in at $0.91 for the December quarter, up from $0.87 the year before and topping the FactSet-polled consensus of $0.89. Sales slipped...
Copyright 2023-2026 - www.financetom.com All Rights Reserved